Hepa Wash News


Federal Institute for Drugs and Medical Devices approves two clinical trials to evaluate the Hepa Wash liver dialysis device Munich - Tuesday, August 03, 2010 The German Federal Institute for Drugs and Medical devices (BfArM) authorized the start of two clinical trials for a liver support therapy developed by the Munich-based medical device company Hepa Wash GmbH. The approval process examined the technical requirements as well as the plausibility of the study design. In March, Hepa Wash already received the required favorable opinion of the Ethics Committee of the hospital rechts der Isar of the Munich Technical University. >>>
HEPA WASH CLOSES €3.8M SERIES-A FINANCING ROUND Munich, Germany - Sunday, December 06, 2009 Hepa Wash GmbH (Hepa Wash) announced the successful closing of its Series-A financing round, raising €3.8m from a syndicate of new and existing private investors as well as the KfW. Hepa Wash, a medical device company developing an innovative liver assist device, announced today the closure of its € 3.8m Series-A financing round. This financing will allow Hepa Wash to develop the first generation machine to start clinical studies in spring 2010. >>>
Hepa Wash and II. Medical Department, University Hospital Rechts der Isar Awarded € 425,000 Grant from the Bayerische Forschungsstiftung (BFS) for a € 0.9 Mio Collaborative Preclinical Study on Acute Liver Failure Munich, Germany - Monday, April 28, 2008 Hepa Wash GmbH (Hepa Wash), a medical device company developing an innovative liver support device announced today that it has received a € 425,000 grant from the Bayerische Forschungsstiftung (BFS) to test the safety and efficacy of its laboratory prototype in a preclinical animal model for acute liver failure in collaboration with the II. Medical Department, University Hospital Rechts der Isar. >>>
Hepa Wash Awarded BayTOU Grant Munich, Germany - Friday, September 14, 2007 Hepa Wash GmbH (Hepa Wash), a medical device company dedicated to the development of next-generation liver support systems announced today that it has received a € 120,000 BayTOU grant from the Bavarian Government for the development of its novel and proprietary technology for the treatment of patients with liver failure. >>>
Hepa Wash Closes Seed Financing Round of €1.1 Million Munich, Germany - Tuesday, May 29, 2007 Hepa Wash GmbH (Hepa Wash), a medical device company dedicated to the development of next-generation liver support systems announced today the closing of a seed-financing round of €1.1 million led by a group of experienced private investors. The new funds will be used to further establish its novel and proprietary technology for the treatment of patients with liver failure and to fund animal trials. >>>